339Curated trials
Enterprise Evidence Report · NR-REPORT-V2.0
Italy
Neuroscience Intelligence
Italy neuroscience evidence report: current clinical, research, institution and source-linked intelligence.
Evidence rank #7 of 50 · Data maturity A · Research score 50.1 · Data confidence 100.0 / 100 · Snapshot 2026-10-12 03:35 UTC.
117Recruiting trials
710Publications
323Institutions
Executive interpretation
Italy ranks #7 in the current NeuroRisk evidence-ranked market layer. This ranking summarizes indexed clinical, publication and institution evidence; it is not a probability of commercial success and not an investment recommendation.
Methodology status
Methodology NR-REPORT-V2.0. No synthetic ML confidence is presented as scientific probability. Counts and source links below are tied to the generation snapshot.
Methodology →Leading sponsors
Merck Sharp & Dohme LLC189 recruiting
Hoffmann-La Roche176 recruiting
IRCCS Eugenio Medea83 recruiting
Fondazione Policlinico Universitario Agostino Gemelli IRCCS73 recruiting
IRCCS San Raffaele62 recruiting
IRCCS Centro Neurolesi Bonino Pulejo63 recruiting
Eli Lilly and Company50 recruiting
Fondazione Don Carlo Gnocchi ETS53 recruiting
Biogen51 recruiting
I.R.C.C.S. Fondazione Santa Lucia53 recruiting
Disease activity
Parkinsons68trials
Alzheimers44trials
Epilepsy33trials
Stroke23trials
Autism20trials
Other Neurology18trials
Neuromuscular16trials
Multiple Sclerosis13trials
Depression11trials
Migraine Headache9trials
Research institutions
European Space Research InstituteOpenAlexlinked institution
Istituto NanoscienzeOpenAlexlinked institution
National Enterprise for NanoScience and NanoTechnologyOpenAlexlinked institution
Ospedale di MiranoOpenAlexlinked institution
Ospedale Maria VittoriaOpenAlexlinked institution
Magna Graecia UniversityOpenAlexlinked institution
University of InsubriaOpenAlexlinked institution
Institute of Organic Synthesis and PhotoreactivityOpenAlexlinked institution
CMCC Foundation - Euro-Mediterranean Center on Climate ChangeOpenAlexlinked institution
Parent Project OnlusOpenAlexlinked institution
Clinical evidence trail
NCT07798674TreatHSP Platform: Adaptive Natural History Platform for Ataxias, HSPs, and Spastic AtaxiasRECRUITING
NCT07732933Testing a New Gold Nanoparticle-Based Lithium Delivery Method for Bipolar Disorder in Laboratory ModelsNOT_YET_RECRUITING
NCT07533084Italian Validation of the dNA Scale and Its Correlation With Neurocognitive VariablesNOT_YET_RECRUITING
NCT07502066Clinical Efficacy of a telerehabilItation Protocol, for the Improvement of Balance in Degenerative Neurological DiseasesACTIVE_NOT_RECRUITING
NCT07479914Art of Memory for Cognitive Enhancement in the Monza Brain Health ServiceACTIVE_NOT_RECRUITING
NCT07474779Understanding Alpha-Synuclein Spread in Parkinson's Disease Through Blood Biomarkers and NeuroimagingNOT_YET_RECRUITING
NCT07470138Sleep Disturbance in Subjects With Autism Spectrum Disorders (ASD) in Preschool Age (18-60 Months)RECRUITING
Research evidence trail
PUBMEDBis(monoacylglycero)phosphate (BMP) as a circulating biomarker of lysosomal dysfunction in GNE myopathy.2027-02-15
PUBMEDFrom protection to progression: How CCT/TRiC shapes therapy-induced senescence in glioblastoma multiforme.2027-01-01
PUBMEDContinuous estetrol/drospirenone regimen for the treatment of endometriosis-related pain: preliminary results.2026-12-31
PUBMEDIn memory of Professor Jules Angst: A historian of illness course, a cartographer of bipolarity, and a giant of clinical psychiatry.2026-12-15
PUBMEDPredicting early psychiatric readmission among people with major depressive disorder: A machine learning analysis from the prospective multicentre DEEP READ study.2026-12-15
PUBMEDMDMA administration reduces ethanol drinking and is associated with altered nociceptin and dynorphin system gene expression in alcohol-preferring rats.2026-12-15
PUBMEDAptamer-guided delivery of miR-126 suppresses glioblastoma stem-like cell invasion and tumor progression.2026-12-08
PUBMEDExpanding the clinical and molecular spectrum of SETD5, NEDD4L, and TBL1X related disorders: A case report and literature review.2026-12-05
PUBMEDCranial Neuropathies-Easy to See, Hard to Diagnose: Toward an Integrated Diagnostic Framework for Rare Conditions.2026-12-01
PUBMEDBehavioral and spectral electroencephalographic biomarkers of epileptogenesis, disease progression, and drug resistance in a longitudinal lithium-pilocarpine model of temporal lobe epilepsy.2026-12-01
Sources and provenance
ClinicalTrials.gov provides NCT evidence. PubMed/NCBI and OpenAlex provide research metadata. OpenAlex links institutions. World Bank indicators are included only when an explicit source row and year exist. NeuroRisk transformations add normalization, ranking and graph connections.
Limitations
Indexed corpus counts are not guaranteed exhaustive global totals. Scores are comparative decision-support signals. This report is not medical advice, regulatory advice, patent clearance, an investment recommendation or a guarantee of outcome.